These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24590650)

  • 1. What is your gut feeling about opioid rotation?
    Didwaniya N; Reddy A; Gottumukkala RS; Bruera E
    J Clin Oncol; 2015 Jan; 33(3):e11-2. PubMed ID: 24590650
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric palliative care: use of opioids for the management of pain.
    Zernikow B; Michel E; Craig F; Anderson BJ
    Paediatr Drugs; 2009; 11(2):129-51. PubMed ID: 19301934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
    Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
    Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid rotation in the treatment of joint pain. A review of 67 cases.
    Grilo RM; Bertin P; Scotto di Fazano C; Coyral D; Bonnet C; Vergne P; Treves R
    Joint Bone Spine; 2002 Oct; 69(5):491-4. PubMed ID: 12477234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
    Juba KM; Wahler RG; Daron SM
    J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid Rotation in Cancer Pain Treatment.
    Schuster M; Bayer O; Heid F; Laufenberg-Feldmann R
    Dtsch Arztebl Int; 2018 Mar; 115(9):135-142. PubMed ID: 29563006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral oxymorphone (Opana).
    Med Lett Drugs Ther; 2007 Jan; 49(1251):3-4. PubMed ID: 17179898
    [No Abstract]   [Full Text] [Related]  

  • 11. Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patients.
    Solassol I; Bressolle F; Caumette L; Garcia F; Poujol S; Culine S; Pinguet F
    Ther Drug Monit; 2005 Aug; 27(4):491-8. PubMed ID: 16044107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?
    Heidemann AJ; Seaton TL
    J Fam Pract; 2001 Oct; 50(10):897. PubMed ID: 11674896
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Concentrations in Oral Fluid and Plasma in Cancer Patients With Pain.
    Heiskanen T; Langel K; Gunnar T; Lillsunde P; Kalso EA
    J Pain Symptom Manage; 2015 Oct; 50(4):524-32. PubMed ID: 25242020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing methadone, a unique analgesic.
    Manfredi PL; Houde RW
    J Support Oncol; 2003; 1(3):216-20. PubMed ID: 15334878
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain.
    Wallace M; Rauck RL; Moulin D; Thipphawong J; Khanna S; Tudor IC
    J Int Med Res; 2008; 36(2):343-52. PubMed ID: 18380946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution to variability in response to opioids.
    Hanks GW; Reid C
    Support Care Cancer; 2005 Mar; 13(3):145-52. PubMed ID: 15761703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Opioid rotation in pain therapy. Case report].
    Kefalianakis F; Kugler M; van der Auwera R; Kugler G
    Anaesthesist; 2002 Jan; 51(1):28-32. PubMed ID: 11963297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations.
    Manfredi PL; Borsook D; Chandler SW; Payne R
    Pain; 1997 Mar; 70(1):99-101. PubMed ID: 9106815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.